I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

The immunocompromised population is increasing worldwide. Aspergillosis is one of the devastating comorbidities in the patients with insufficient immunity. *Aspergillus* species are ubiquitous, and *Aspergillus fumigatus* is the primary causative agent of human infections. Aspergilla produce small, hydrophobic conidia that disperse easily into the air and can survive a broad range of environmental conditions.\[[@ref1]\] *A. fumigatus* causes a wide range of human diseases depending on the immune status of the host. For instance, in patients with asthma or cystic fibrosis, aspergilla can cause allergic bronchopulmonary aspergillosis, a hypersensitive response to fungal components. While noninvasive aspergillomas may form following repeated exposure to conidia in some patients such as healed tuberculosis, invasive aspergillosis may be the most devastating of *Aspergillus*-related diseases, targeting severely immunocompromised patients such as cancer patients, organ transplantation patients, patients on prolonged corticosteroid therapy, or acquired immune deficient disease patients.\[[@ref1][@ref2]\]

CD8^+^ T-cell is a vital component of the adaptive immune system and important for eliminating intracellular pathogens.\[[@ref3][@ref4]\] CD8^+^ T-cells are activated through their T-cell receptor (TCR) followed by secreting cytokines and functioning as effector cells. Following infection or peptide stimulation, small numbers of naïve CD8^+^ T-cells expand to form a large effector population. When the large population of effector CD8^+^ T undergoes contraction or apoptosis, a smaller long-lived memory CD8^+^ T-cells will be responsible to protect the host from subsequent reinfection with the same pathogen by quickly expanding and rapidly expressing lytic activity and effector cytokines.\[[@ref5]\] In this regard, we have previously reported that a number of CD8^+^ T-cells significantly decreased at an early stage of invasive pulmonary aspergillosis (IPA) and that the IPA patients' prognosis was associated with differentiation of CD8^+^ T-cells.\[[@ref6][@ref7]\] Thus, the current study was designed to further investigate the mechanisms of regulating CD8^+^ T-cell differentiation in an animal model of cyclophosphamide (CTX)-induced immune suppression and *Aspergillus* infection.

mTOR is a serine/threonine kinase with the ability to integrate environmental stimuli to regulate cell metabolism, survival, growth, and proliferation. mTor forms two complexes, mTORC1 and mTORC2, with distinct signaling properties and sensitivities to rapamycin. mTORC1 phosphorylates S6K1, a 4EBP-1 to promote protein translation, and is sensitive to rapamycin inhibition.\[[@ref8]\] Recent studies have indicated that mTOR may regulate T-cell differentiation and adaptive immunity following the binding of TCR to antigens.\[[@ref8][@ref9]\] Transcription factors T-box expressed in T-cells (T-bet) and eomesodermin (EOMES) are important transcription factors which regulate the effector T-cell and participated in the process of the differentiation and development of CD4 effector I type T-cells, helper T-cells, Th1 cells, NK cells, and CD8^+^ cytotoxic T lymphocyte. Many studies had shown that T-bet and Eomes involved in the regulation of CD8^+^ T-cells into effector T-cells and memory T-cells.\[[@ref10][@ref11][@ref12]\]

Therefore, the role of mTOR and downstream T-bet and EOMES in modulating T-cell differentiation in immunocompromised animal models of IPA was explored in the current study.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Pathogen preparation {#sec2-1}
--------------------

The strain of *A. fumigatus* was obtained from a case of pulmonary aspergillosis at the Peking Union Medical College Hospital. Viable conidia (\>95%) were obtained by growth on Sabouraud dextrose agar for 5 days at 35°C. Conidia was harvested with 10 ml 0.1% Tween-80 and filtered through five-layer of gauze. The concentration of conidia was adjusted to 1 × 10^8^ CFU/ml by the method of turbidity adjustment.

Animal model preparation {#sec2-2}
------------------------

Healthy Wistar rats, male, 7--8 weeks old, and weight of 220 ± 20 g were obtained from the Animal Facility Center, Peking Union Medical College Hospital. All animals were housed in a pathogen-free facility and used according to protocols approved by the IACUC of Peking Union Medical College Hospital. Total 35 rats were randomly divided into the following groups (five animals each group or subgroup): (1) control group (CON): nontreated normal rats. (2) Immune suppression group (CTX): animals were treated with CTX only. (3) IPA group: animals were infected with *A. fumigatus*. (4) Immune suppression plus aspergillosis group (CTX + IPA): animals were given CTX and infected with *A. fumigatus*. CTX + IPA group was further subgrouped by the time of posttreatment: CTX + IPA-24 h, -48 h, -72 h, and -96 h subgroups. Regarding to IPA group, the rats were sacrificed after aspergillosis injection 96 h.

CTX (Jiangsu Hengrui Medicine Co., Ltd., China) was injected intraperitoneally at a dose of 200 mg · kg^−1^· d^−1^, for 5 consecutive days. Tracheostomy was then performed under systemic anesthesia followed by intratracheal instillation of 0.1 ml conidia solution. Animals were sacrificed at 24 h, 48 h, 72 h, and 96 h after intratracheal instillation of the conidia, respectively. Blood samples were obtained through the heart-punctuation. Part of lung tissue was minced and used for *A. fumigatus* culture. Part of lung tissue was also fixed with 4% formaldehyde, and sections were stained with hematoxylin and eosin for histology.

CD8^+^ T-cells and memory CD8^+^ T-cell count {#sec2-3}
---------------------------------------------

Mononuclear cells were isolated from blood samples and counted. Cells were then labeled with the following fluorescence-conjugated monoclonal antibodies: anti-Rat CD45 PE, anti-Rat CD8a APC, anti-Rat CD44 PE, and anti-Rat CD62L (eBioscience, San Diego, CA, USA). CD8^+^ T-cells and memory CD8^+^ T-cells were sorted by flow cytometry (EPICS-XL, Beckman-Coulter, USA).

Cytokine quantification {#sec2-4}
-----------------------

Cytokines or proteins of transcription factors were quantified using the enzyme-linked immunosorbent assay kits following the manufacture\'s instruction. mTOR: cat\# ab168538, Abcam, Cambridge, MA, USA. S6K: cat\#: ab176665, Abcam, Cambridge, MA, USA. T-bet: cat\#: 85-86051, Affymetrix eBioscience, San Diego, CA, USA. EOMES: cat\# MBS078844, MyBioSource, San Diego, CA, USA.

Statistical analysis {#sec2-5}
--------------------

Data were analyzed by SPSS 18.0 software (SPSS Inc., IBM Corp., Armonk, NY, USA). All the data for the continuous variables in this study were proved to be normal distributions, which are given as mean ± standard deviation (SD). Results for continuous variables that were not normally distributed are given as medians (interquartile ranges) and were compared using non-parametric tests. Student\'s *t*-test or analysis of variance (ANOVA) followed by Bonferroni\'s test was used to determine the statistical significance (*P*) of differences. Pearson\'s correlation coefficient was used to analyze the correlation of two parameters. A *P* \< 0.05 was considered as statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Laboratory blood test {#sec2-6}
---------------------

As shown in [Figure 1](#F1){ref-type="fig"}, total number of white blood cells were significantly decreased in the animals of CTX group \[5.8 (5.1--8.2) ×10^9^/L\] and CTX + IPA groups \[0.18 (0.07--0.24) ×10^9^/L, 0.03 (0.02--0.10) ×10^9^/L, 0.05 (0.03--0.30) ×10^9^/L, 0.06 (0.04--0.13) ×10^9^/L, respectively for 24 h, 48 h, 72 h, 96 h\] compared to that of normal control group \[5.67 (3.50--9.00) ×10^9^\] and *Aspergillus fumigatus*-infected IPA group \[0.1 (0.1--0.4) ×10^9^/L\] (*P*\< 0.001). The neutrophils \[0.54 (0.26--1.35)×10^9^/L, 3.36 (0.31--3.57) ×10^9^/L, 0.02 (0.01--0.40) ×10^9^/L, 0.04 (0.02--0.06)×10^9^/L, 0.02 (0.01--0.03) ×10^9^/L, 0.02 (0.01--0.08) ×10^9^/L, 0.02 (0.02--0.04) ×10^9^/L, respectively for CON group, CTX group, IPA group, 24 h, 48 h, 72 h, 96 h\] and lymphocytes 3.97 (2.02--6.52)×10^9^/L, 2.61 (2.06--3.52) ×10^9^/L, 0.06 (0.05--0.20) ×10^9^/L, 0.06 (0.03--0.08) ×10^9^/L, 0.008 (0.003--0.030)×10^9^/L, 0.006 (0.006--0.014)×10^9^/L, respectively for CON group, CTX group, IPA group, 24 h, 48 h, 72 h, 96 h) were the same as white blood cells. There was no significant difference in blood cell counts among the samples of CTX + IPA collected at 24 h, 48 h, 72 h, or 96 h after infection. Neutrophils were significantly increased while lymphocytes were significantly decreased in IPA group compared to that in normal control group (*P* \< 0.01).

![White blood cell, neutrophil, and lymphocytes in the blood of animal models (*n* = 5 each group). (a) Total white blood cell count. (b) Neutrophil count. (c) Lymphocytes count. Vertical axes: cell number (×10^9^/L). Horizontal axes: Groups \**P* \< 0.05.](CMJ-129-1704-g001){#F1}

Tissue culture and histology {#sec2-7}
----------------------------

Viability of the conidia was examined by culturing infected lung tissue. Viable *A. fumigatus* was positively cultured in both IPA and CTX + IPA groups, while it was negative in control and CTX groups (data not shown). Histological examination indicated that lung tissue structure was intact in normal \[[Figure 2a](#F2){ref-type="fig"}\] and CTX-treated rat lungs \[[Figure 2b](#F2){ref-type="fig"}\]. In contrast, infiltration of inflammatory cells, blood congestion, and interstitial lung tissue injury was found in the rat lungs of IPA-infected \[[Figure 2c](#F2){ref-type="fig"}\] or CTX + IPA infection for 24 h \[[Figure 2d](#F2){ref-type="fig"}\]. At 48 h after CTX + IPA infection, congestion, hemorrhage, and hyphae were seen in the interstitial lung tissue \[Figure [2e](#F2){ref-type="fig"} and [2h](#F2){ref-type="fig"}\]. At 72 h and 96 h after CTX + IPA infection, severe alveolar injury, thickness of interstitial tissue, and alveolar infiltration were further noticed \[Figure [2f](#F2){ref-type="fig"} and [2g](#F2){ref-type="fig"}, respectively\].

![Histology of lung tissue stained with H and E. (a) Control animal. (b) Animals treated with CTX. (c) Animals with IPA. (d) Animals with CTX + IPA for 24 h. (e and h) Animals with CTX + IPA for 48 h. (f) Animals with CTX + IPA for 72 h. (g) Animals with CTX + IPA for 96 h. (h) The mycelium of pulmonary aspergillosis. (a-g: original magnification ×20); (h: original magnification ×40). CTX: Cyclophosphamide; IPA: Invasive pulmonary aspergillosis.](CMJ-129-1704-g002){#F2}

Alteration of CD8^+^ T-cells and memory CD8^+^ T-cells {#sec2-8}
------------------------------------------------------

As shown in [Figure 3](#F3){ref-type="fig"}, compared to control (15.95 ± 1.09%) and IPA group (14.07 ± 3.27%), proportion of CD8^+^ T-cell was significantly increased in the CTX group (21.14 ± 1.91%) and subgroups of CTX + IPA at 24h (17.85 ± 1.16%), 48 h (21.71 ± 4.11%), 72 h (23.64 ± 3.73%), and 96 h (24.41 ± 3.70%) animals (*P* \< 0.05). In addition, CD8^+^ T-cell was significantly higher in the subgroups of CTX + IPA-72 h and CTX + IPA-96 h than that of CTX + IPA-24 h subgroup (*P*\< 0.05). Similarly, compared to control group (0.85 ± 0.13%) and IPA group (0.70 ± 0.44%), proportion of memory CD8^+^ T-cells was significantly increased in the subgroups of CTX + IPA-24h (1.45 ± 0.40%), -48 h (3.16 ± 0.69%), -72 h (200 ± 0.66%), and -96 h (2.25 ± 0.61%) animals (*P* \< 0.05).

![Comparison of CD8^+^ T-cells (a) and memory CD8^+^ T-cells (b). CD8^+^ T-cells and memory CD8^+^ T-cells were sorted by flow cytometry as described in the methods. Vertical axes: percent of CD8^+^ T-cells (%) or memory CD8^+^ T-cells (%). Horizontal axes: Groups \**P* \< 0.05.](CMJ-129-1704-g003){#F3}

Alteration of serum mTOR, S6K proteins, eomesodermin, and T-bet proteins {#sec2-9}
------------------------------------------------------------------------

As shown in Figure [4a](#F4){ref-type="fig"} and [4b](#F4){ref-type="fig"}, serum level of mTOR and S6K was significantly higher in the groups of CTX-treated (99.13 ± 3.53 ng/ml; 15.73 ± 0.33 U/L) and IPA-infected (83.72 ± 13.44 ng/ml; 13.13 ± 2.18 U/L) rats than that of control (56.53 ± 5.99 ng/ml; 9.5 ± 0.23 U/L) group (*P* \< 0.001). At early stage of CTX + IPA, i.e., 24 h (112.24 ± 5.91 ng/ml; 19.53 ± 0.82 U/L) and 48 h (128.34 ± 12.5 ng/ml; 19.63 ± 0.94 U/L), serum level of mTOR and S6K was higher than that of control (*P* \< 0.001); 72 h (46.68 ± 10.05 ng/ml; 8.71 ± 1.93 U/L) and 96 h (64.65 ± 14.23 ng/ml; 11.32 ± 2.45 U/L) (at later stage of infection), however, serum level of mTOR and S6K was significantly decreased (*P* \< 0.05) and close to the level of control group.

As shown in Figure [4c](#F4){ref-type="fig"} and [4d](#F4){ref-type="fig"}, compared to control group (8.38 ± 0.51 ng/ml; 340.03 ± 26.32 pg/ml), serum level of EOMES (*P* \< 0.001) and T-bet (*P* \< 0.05) was significantly higher in the groups of IPA (5.69 ± 1.07 ng/ml; 443.03 ± 48.1 pg/ml) and CTX + IPA at 24 h (3.97 ± 0.35 ng/ml; 647 ± 33.03 pg/ml) and 48 h (4.00 ± 0.74 ng/ml; 619.23 ± 87.44 pg/ml). Serum level of EOMES and T-bet in the groups of CTX + IPA-72 h (8.38 ± 0.54 ng/ml; 299.64 ± 63.07 pg/ml) and -96 h (8.4 ± 0.7 ng/ml; 398.02 ± 109.22 pg/ml), however, was significantly lower than that in the groups of CTX + IPA-24 h or -48 h (*P* \< 0.001).

![Serum levels of mTOR (a), S6K (b), EOMES (c), and T-bet (d). Serum was harvested, and protein levels of mTOR, S6K, EOMES, and T-bet were quantified by enzyme-linked immunosorbent assay as described in the methods. Vertical axes: Amount of mTOR (ng/ml) or S6K (U/L) or EOMES (ng/ml) or T-bet (pg/ml). Horizontal axes: Groups \**P* \< 0.05. EOMES: Eomesodermin.](CMJ-129-1704-g004){#F4}

Correlation between mTOR or S6K and eomesodermin or T-bet {#sec2-10}
---------------------------------------------------------

Pearson\'s correlation analysis indicated serum mTOR was significantly correlated with T-bet (*r* = 0.901, *P* \< 0.001), but negatively and significantly correlated with EOMES \[*r* = −0.758, *P* \< 0.001, Figure [5a](#F5){ref-type="fig"} and [5b](#F5){ref-type="fig"}\]. Similarly, serum level of S6K was significantly correlated with T-bet (*r* = 0.91, *P* \< 0.001), but negatively and significantly correlated with EOMES \[*r* = −0.751, *P* \< 0.001, Figure [5c](#F5){ref-type="fig"} and [5d](#F5){ref-type="fig"}\].

![Correlation between mTOR, S6K, EOMES, and T-bet. (a) mTOR and EOMES. (b) mTOR and T-bet. (c) S6K and EOMES. (d) S6K and T-bet. EOMES: Eomesodermin.](CMJ-129-1704-g005){#F5}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

In the current study, we demonstrated that CTX-induced immune suppression resulted in significant decrease of lymphocytes. Ratio of CD8^+^ T-cells memory CD8^+^ T-cells was significantly increased in early stage, but decreased in the late stage of *A. fumigatus*-infection in the animals of CTX-induced immune suppression (CTX + IPA). Furthermore, serum level of mTOR and S6K was also altered in consistence with the alteration of CD8^+^ T-cell number and was significantly correlated with the level of T-bet or negatively but significantly correlated with EOMES.

CD8^+^ T-cells play an important role in adaptive immunity. Following infection, CD8^+^ T-cells undergo proliferation and differentiation under stimulation of antigens, co-stimulators and cytokines such as interferon-γ.\[[@ref13]\] Differentiation of CD8^+^ T-cell is regulated by several transcription factors and signal transduction pathways. Ratio and number of different phenotypes of CD8^+^ T-cells determine the function of CD8^+^ T-cells.\[[@ref14]\] It has been reported that different pathogens may induce CD8^+^ T-cells into different phenotypes, which closely related with host defense mechanism in the secondary infection.\[[@ref15][@ref16]\] Immunocompromised patient is highly in risk to severe infection and secondary infection. It is crucial for these patients to have an immune response in the early stage of infection in order to develop adaptive immunity in the late phase of infection. Memory CD8^+^ T-cells are believed to play an important role in the development of adaptive immunity. Consistent with this concept, the current study demonstrated that CD8^+^ T-cells were significantly increased following the immune suppression by CTX and *A. fumigatus* -infection, especially memory CD8^+^ T-cells were significantly increased 48 h after fungal infection in the immunocompromised animals, suggesting resident CD8^+^ T-cells play an important role in forming adaptive immunity in response to a fungal infection. At 72 h and 96 h after fungal infection, however, ratio and number of CD8^+^ T-cells were gradually decreased, indicating re-population of effector cells from memory CD8^+^ T may require longer time after the contraction of early stage effector cells.

mTOR plays an important role in regulating T-cell immune function. Studies indicated that mTOR contribute to proliferation and differentiation of T-cells in response to antigen stimulation\[[@ref17][@ref18]\] and that mTOR modulates expression of TCR, CD28, and programmed death 1, by which mechanism, mTOR regulates antigen recognition and adaptive immune reaction of T-cells.\[[@ref19][@ref20]\] In the current study, the serum level of mTOR and S6K was significantly increased in the rats treated with CTX with or without fungal infection (CTX + IPA-24 h and -48 h), suggesting mTOR signal transduction pathway was activated in the animals with immune suppression and fungal infection.

Studies have demonstrated that several intracellular signal transduction pathways and transcription factors including pathways of tyrosine kinase, anti-inflammatory signal, and mitochondrial apoptosis involve in regulating T-cell differentiation.\[[@ref19][@ref20][@ref21][@ref22][@ref23][@ref24]\] In addition to these signal transduction pathways, it is also likely that mTOR involve in immune activation and regulation following infection. In this content, mTOR signaling pathway also acts as an important integrator of nutrient-sensing pathways, which in turn control and coordinate the metabolism of the cells according to this need to proliferate or functionally differentiate. Interestingly, the current study found that serum level of mTOR and S6K was increased in early stage of fungal infection (24 h and 48 h), but significantly decreased at late stage (72 h and 96 h), suggesting mTOR and S6K may be involved in re-populating effector T-cells from memory CD8^+^ T-cells after the contraction of early stage effector cells. Mechanism of this retraction of mTOR and S6K level, however, remains to be further defined.

T-bet and EOMES are a family of T-box and regulate effector T-cell differentiation. T-bet is known to regulate Th1 cell differentiation and inflammatory cytokine production, while EOMES involves in modulating CD8^+^ T differentiation in the late phase of infection.\[[@ref14]\] Similar to mTOR, these two transcription factors may also be involved in regulating immune response following *Aspergillus* infection. There had also been identified that mTOR as the central regulator of transcriptional programs that determine effector and/or memory cell fates in CD8^+^ T-cells.\[[@ref12]\] The findings of the current study demonstrated that T-bet was significantly increased in the immunocompromised animals with a fungal infection, especially at 48 h after infection. In contrast, EOMES was significantly decreased after 24 h and 48 h of infection. Furthermore, we found that mTOR and S6K were significantly and negatively correlated with EOMES, while they were significantly correlated with T-bet. These findings suggested that mTOR might modulate immune cell differentiation through the transcription factors T-bet and EOMES.

There are some limitations of our study. First, although we found that mTOR/S6K levels positively correlated with T-bet and negative correlated with the EOMES, the mechanism of this phenomenon remains unclear. It is still unknown whether we can regulate the activity of molecular signaling pathways to establish the immunity adaption. It is necessary to reveal that the effect of inhibiting the corresponding mTOR/S6K pathway on CD8 memory cells. Second, the detected CD8 memory T-cells are smaller than we originally expected, which may be due to the immunosuppressive animal model or other specific treatment for this study. However, the clear mechanism needs further be studied.

Taken together, serum levels of mTOR, S6K, T-bet, and EOMES were significantly altered in the immunocompromised rats with IPA. Consistent with the alteration of these molecules, number and proportion of memory CD8^+^ T-cells were also significantly altered in a time-dependent manner. These findings indicated that mTOR modulate immune cell proliferation and differentiation through EOMES and T-bet in the immunocompromised animals with IPA. Whether the level of mTOR and its downstream components is altered in CD8^+^ T-cells in the animal model of the current study, however, remains to be further investigated.
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